MOSCOW (Reuters) – Major export deals to supply doses of the Sputnik V vaccine against COVID-19 will be fulfilled over the next six to nine months, the head of Russia’s sovereign wealth fund, Kirill Dmitriev, told a Reuters Next summit on Thursday.
Dmitriev, head of the Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said 95% of the many multi-million-dose export deals the fund had signed would be supplied by manufacturers located outside of Russia.
(Reporting by Polina Ivanova and Tom Balmforth; Writing by Polina Ivanova; Editing by Alison Williams)
